OHSU Multiple Sclerosis Center

Portland, Oregon

Academic MS Center
5 Active TrialsInfusion CenterLarge Center
3 MS centers statewide · Ranked #2 in Oregon for clinical trials · #2 in Oregon for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site

You’re coming to a large academic MS center where many parts of your care can be handled in one place. You’ll likely appreciate the broad team, on-site infusion therapy, and support from specialists in rehabilitation, neuro-ophthalmology, pain, and urology.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research5/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care2/5

About OHSU Multiple Sclerosis Center

This center combines MS specialty care with a broad neuroimmunology program, including autoimmune encephalitis, NMOSD, transverse myelitis, and optic neuritis care. It also stands out for its on-site infusion services, research activity, and formal fellowship training in MS and neuroimmunology.

OHSU Multiple Sclerosis Center serves people with multiple sclerosis, clinically isolated syndrome, and other demyelinating and neuroimmune disorders such as NMOSD, transverse myelitis, optic neuritis, and autoimmune encephalitis. You can get diagnostic testing, treatment, rehabilitation support, pain management, neuro-ophthalmology, urology, and neuropsychology services in one academic setting. The center also offers an on-site infusion model, provider-to-provider advice, and a fellowship program in MS and neuroimmunology. Patients can also take part in education, wellness programming, and research-related activities.

OHSU Multiple Sclerosis Center is an academic MS center in Portland that cares for people with MS and a wide range of related neurologic conditions. You'll find a multidisciplinary team that includes neurologists, therapists, psychologists, urologists, pharmacists, and researchers working together on your care. It also has on-site infusion therapy and a strong connection to research and training at OHSU.

Featured Care Team Members

Jacqueline T. Bernard, M.D., FAAN
Neurology provider
Multiple sclerosis and related disorders
Dennis Bourdette, M.D., FANA, FAAN
Founder of the MS Center
Multiple sclerosis and research
Michael Lane, M.D.
Neurologist
Autoimmune encephalitis
Vijayshree Yadav, M.B.B.S., M.C.R., FANA, FAAN
Director of the OHSU Multiple Sclerosis Center
Multiple sclerosis and neuroimmunology
Elizabeth Silbermann, M.D.
Physician scientist
Multiple sclerosis
Rebecca Spain, M.D., M.S.P.H., FAAN
Physician scientist
Multiple sclerosis
Jacqueline Bernard, M.D.
Active MS Prescriber
Ratna Bitra, M.D.
Active MS Prescriber
Vicky Chen, M.D.
Elizabeth Silbermann, M.D.
Vijayshree Yadav, MD
Active MS Prescriber

Specialized Programs

MS Wellness Research Group
Rehabilitation services
MS and Neuroimmunology Fellowship
Case conferences for care coordination
Research program
Patient stories
Annual MS symposium

Partnerships & Referral Network

  • OHSU Casey Eye Institute (optic neuritis care)
  • OHSU Comprehensive Pain Center (pain management)
  • OHSU Neuro Genetics Clinic (genetic counseling)

Services & Treatments

What They Treat
Multiple sclerosisClinically isolated syndromeRelapsing-remitting multiple sclerosisPrimary progressive multiple sclerosisSecondary progressive multiple sclerosisDemyelinating disordersAutoimmune encephalitisNeuromyelitis optica spectrum disorder (NMOSD)Transverse myelitisOptic neuritisLeukodystrophySusac syndromeRadiologically isolated syndromeDisorders linked to multiple sclerosis
How They Treat It
Multiple sclerosis diagnosisMultiple sclerosis treatmentCare for related demyelinating and neuroimmune disordersAutoimmune encephalitis careNeuromyelitis optica spectrum disorder careTransverse myelitis careOptic neuritis careNeuropsychologyRehabilitation therapyPain managementUrologyNeuro-ophthalmologySleep disorders evaluationGenetic counseling referralPatient referral and provider-to-provider adviceResearch participationDisease-modifying therapiesOcrelizumabCorticosteroidsMethylprednisolonePrednisonePlasma exchange therapy (PLEX)Intravenous immunoglobulin (IVIG)Immunosuppressant medicationsCannabis in pill formOromucosal cannabinoid sprayAcupunctureTai chiYogaVitamin D supplementsLow-fat dietVery low-fat vegan dietExerciseRelaxation exercisesPhysical therapyOccupational therapySpeech-language therapyElectrical stimulation rehabilitation devicesFES bikeBionessLokomat body-weight-supported treadmill
Diagnostics
MRISpinal tap (lumbar puncture)Evoked potential studyBlood testsNeurologic examEye testsNeuropsychological evaluation

Research & Clinical Trials

This center is currently involved in 5 clinical trials — ranked #2 in Oregon for active trials

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
RECRUITINGPHASE1
CC-97540FludarabineCyclophosphamide
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE3
Autologous Hematopoietic Stem Cell TransplantationBest Available Therapy (BAT)
MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect
Ad scientiam
ACTIVE NOT RECRUITINGNA
MSCopilot® Detect mobile application
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals
RECRUITINGPHASE2
rapcabtagene autoleucelrituximab
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
everolimus

Insurance & Access

Contact
Center for Health & Healing, 3303 SW Bond Avenue Fl 8, Portland, OR 97239
Insurance & Support

FAQs from OHSU Multiple Sclerosis Center

The center treats multiple sclerosis, clinically isolated syndrome, radiologically isolated syndrome, and several related neurologic conditions. This includes NMOSD, transverse myelitis, optic neuritis, autoimmune encephalitis, leukodystrophy, and Susac syndrome.

Yes. The center has an on-site infusion model and lists treatments such as ocrelizumab, corticosteroids, plasma exchange therapy, IVIG, and immunosuppressant medications.

Diagnostic services include MRI, spinal tap, evoked potential studies, blood tests, neurologic exams, eye tests, and neuropsychological evaluation. These tests help the team evaluate MS and related disorders.

You can access rehabilitation therapy, pain management, urology, neuro-ophthalmology, sleep disorders evaluation, and genetic counseling referral. The team also includes physical, occupational, and speech-language therapists.

Yes. A doctor referral is required to become a patient at this center. You can call 503-494-7772 for appointment-related help.

Compare Oregon MS Centers

CenterTypeInfusionVirtualExperience
OHSU Multiple Sclerosis Center
Portland
Academic MS Center3.4/5
Dedicated MS Practice3.4/5
Regional Neurology Group1.6/5

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website